We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

99 hedge funds and large institutions have $81.7M invested in 9 Meters Biopharma in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 31 increasing their positions, 14 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 14

36% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 25

10% more funds holding

Funds holding: 90 → 99 (+9)

8% less capital invested

Capital invested by funds: $88.6M → $81.7M (-$6.91M)

15% less call options, than puts

Call options by funds: $2.56M | Put options by funds: $3M

Holders
99
Holders Change
+9
Holders Change %
+10%
% of All Funds
1.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
31
Reduced
14
Closed
25
Calls
$2.56M
Puts
$3M
Net Calls
-$438K
Net Calls Change
+$185K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$11.9M
2
Deutsche Bank
Deutsche Bank
Germany
+$3.73M
3
State Street
State Street
Massachusetts
+$3.65M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.53M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.38M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$21.1M
2
TLP
Tri Locum Partners
New York
-$7.77M
3
CH
CVI Holdings
Delaware
-$2.5M
4
MWNA
Marshall Wace North America
New York
-$1.73M
5
Citigroup
Citigroup
New York
-$963K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
101
Sabby Management
Florida
– -$693K -28,226 Closed
PCM
102
Perkins Capital Management
Minnesota
– -$410K -17,500 Closed
ECM
103
ExodusPoint Capital Management
New York
– -$347K -14,809 Closed
Walleye Capital
104
Walleye Capital
New York
– -$176 -7,500 Closed
JG
105
Jefferies Group
New York
– -$162K -6,916 Closed
Nomura Holdings
106
Nomura Holdings
Japan
– -$162K -6,675 Closed
LP
107
LMR Partners
United Kingdom
– -$123K -5,247 Closed
SC
108
Saltoro Capital
Texas
– -$105K -4,500 Closed
Goldman Sachs
109
Goldman Sachs
New York
– -$103K -4,410 Closed
IC
110
IEQ Capital
California
– -$98K -4,200 Closed
Tudor Investment Corp
111
Tudor Investment Corp
Connecticut
– -$84K -3,605 Closed
SSA
112
Schonfeld Strategic Advisors
New York
– -$67K -2,863 Closed
Balyasny Asset Management
113
Balyasny Asset Management
Illinois
– -$49K -2,093 Closed
MA
114
MYDA Advisors
New York
– -$47K -2,000 Closed
Capstone Investment Advisors
115
Capstone Investment Advisors
New York
– -$45K -1,935 Closed
CWS
116
Cypress Wealth Services
California
– -$30K -1,275 Closed
SM
117
Sciencast Management
New Jersey
– -$13K -555 Closed
PCM
118
Prelude Capital Management
New York
– -$12K -500 Closed
APWA
119
Atlas Private Wealth Advisors
New Jersey
– -$6K -250 Closed
Simplex Trading
120
Simplex Trading
Illinois
– +$491 +20 New
1 2 3 4
5

NMTR Hedge Fund Activity: Q2 2021 in Review

99 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q2 2021, worth a combined $81.7M — down 7.8% from $88.6M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new NMTR positions and 25 closed out — a net gain of 9 holders — while 31 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $11.9M. The largest seller was OrbiMed, cutting an estimated $21.1M.

  • 99 institutional investors held 9 Meters Biopharma (NMTR) as of Q2 2021, up from 90 in Q1 2021.
  • Funds reported $81.7M of 9 Meters Biopharma stock for Q2 2021, down 7.8% quarter-over-quarter.
  • 34 funds opened new 9 Meters Biopharma positions in Q2 2021 and 25 closed out, a net change of +9 holders.
  • The largest 9 Meters Biopharma buyer in Q2 2021 was BlackRock, an estimated $11.9M added.
  • The largest 9 Meters Biopharma seller in Q2 2021 was OrbiMed, an estimated $21.1M sold.

Based on aggregated 13F filings for Q2 2021.